Literature DB >> 26219893

Biological roles of microRNA-140 in tumor growth, migration, and metastasis of osteosarcoma in vivo and in vitro.

Rui Gu1, Yi-Fu Sun1, Min-Fei Wu2, Jia-Bei Liu1, Jin-Lan Jiang3,4, Shuai-Hua Wang5, Xin-Lei Wang5, Qiang Guo5.   

Abstract

The objective of this study was to explore the biological roles of microRNA-140 (miR-140) in tumor growth, migration, and metastasis of osteosarcoma (OS) in vivo and in vitro. Between 2007 and 2014, 47 cases of OS samples and normal bone tissue samples adjacent to OS were selected from our hospital. Tissue biopsies from OS patients were used to measure miR-140 levels to obtain a correlation between clinicopathological features and miR-140 expression. In vitro, MG63 human osteosarcoma cells were divided into four groups: blank group, miR-140 mimic group, miR-140 inhibitor group, and negative control (NC; empty plasmid) group. qRT-PCR was used to detect miR-140 expression, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to detect cell proliferation, flow cytometry was used to detect cell cycle distribution, and scratch migration assay was used to detect cell migration. In vivo, the relative expression of miR-140 level in OS tissue was lower than that in the adjacent normal bone tissue. miR-140 expression is inversely correlated with tumor size, Enneking stage, and tumor metastasis. In vitro, compared with blank group and NC group, relative miR-140 expression was increased, cell proliferation was inhibited, cell population in G0/G1 phase was increased, cell population in G2/M phase and S phases and proliferation index (PI), and cell migration distance were decreased in the miR-140 mimic group, but the relative expression and all the cell indexes were found opposite trend in the miR-140 inhibitor group. In conclusion, in vivo and vitro findings provided evidence that miR-140 could inhibit the growth, migration, and metastasis of OS cells.

Entities:  

Keywords:  Growth; MG63 cells; Metastasis; MicroRNA-140; Migration; Osteosarcoma

Mesh:

Substances:

Year:  2015        PMID: 26219893     DOI: 10.1007/s13277-015-3801-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

1.  MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin.

Authors:  Ka Bian; Jing Fan; Xiang Zhang; Xin-Wei Yang; Hua-Yu Zhu; Lei Wang; Jian-Yong Sun; Yan-Ling Meng; Peng-Cheng Cui; Shi-Yin Cheng; Jian Zhang; Jing Zhao; An-Gang Yang; Rui Zhang
Journal:  FEBS Lett       Date:  2012-02-01       Impact factor: 4.124

2.  HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study.

Authors:  Sarah Gorlick; Donald A Barkauskas; Mark Krailo; Sajida Piperdi; Rebecca Sowers; Jonathan Gill; David Geller; R Lor Randall; Katherine Janeway; Cindy Schwartz; Holcombe Grier; Paul A Meyers; Richard Gorlick; Mark Bernstein; Neyssa Marina
Journal:  Pediatr Blood Cancer       Date:  2014-04-22       Impact factor: 3.167

3.  microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN.

Authors:  Jian Hua Mao; Rong Ping Zhou; Ai Fen Peng; Zhi Li Liu; Shan Hu Huang; Xin Hua Long; Yong Shu
Journal:  Oncol Lett       Date:  2012-08-16       Impact factor: 2.967

4.  Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.

Authors:  Junfeng Zhu; Yupeng Feng; Zunfu Ke; Zheng Yang; Junyi Zhou; Xiaorong Huang; Liantang Wang
Journal:  Am J Pathol       Date:  2012-04-21       Impact factor: 4.307

5.  Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.

Authors:  Bo Song; Yuan Wang; Matthew A Titmus; Galina Botchkina; Andrea Formentini; Marko Kornmann; Jingfang Ju
Journal:  Mol Cancer       Date:  2010-04-30       Impact factor: 27.401

6.  MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.

Authors:  Fang Ji; Hao Zhang; Yang Wang; Ming Li; Weidong Xu; Yifan Kang; Zhiwei Wang; Zimin Wang; Ping Cheng; Dake Tong; Cheng Li; Hao Tang
Journal:  Bone       Date:  2013-06-10       Impact factor: 4.398

7.  MicroRNA Involvement in Osteosarcoma.

Authors:  Eisuke Kobayashi; Francis J Hornicek; Zhenfeng Duan
Journal:  Sarcoma       Date:  2012-04-03

8.  Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma.

Authors:  Haiqing Cai; Lijun Lin; Haikang Cai; Mingjie Tang; Zhigang Wang
Journal:  Int J Mol Sci       Date:  2014-01-06       Impact factor: 5.923

9.  KLF8 knockdown suppresses proliferation and invasion in human osteosarcoma cells.

Authors:  Feng Lin; Zan Shen; Li-Na Tang; Shui-Er Zheng; Yuan-Jue Sun; Da-Liu Min; Yang Yao
Journal:  Mol Med Rep       Date:  2014-03-07       Impact factor: 2.952

10.  Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma.

Authors:  Sheila Thampi; Katherine K Matthay; W John Boscardin; Robert Goldsby; Steven G DuBois
Journal:  Sarcoma       Date:  2014-09-09
View more
  5 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Multifaceted roles of pericytes in central nervous system homeostasis and disease.

Authors:  Zhitong Zheng; Michael Chopp; Jieli Chen
Journal:  J Cereb Blood Flow Metab       Date:  2020-03-24       Impact factor: 6.200

3.  miR-874 suppresses the proliferation and metastasis of osteosarcoma by targeting E2F3.

Authors:  Dong Dong; Yubao Gong; Debao Zhang; Huricha Bao; Guishan Gu
Journal:  Tumour Biol       Date:  2015-12-02

4.  Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.

Authors:  Wei Liu; Pengcheng Liu; Hang Gao; Xu Wang; Ming Yan
Journal:  Mol Oncol       Date:  2020-08-19       Impact factor: 6.603

Review 5.  Osteosarcoma and Metastasis.

Authors:  Gaohong Sheng; Yuan Gao; Yong Yang; Hua Wu
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.